Skip to main content
  • Investor Home Center
    • Company News
    • Financial News
    • Events & Presentations
      • Events Calendar
      • Presentations
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Annual Reports
      • SEC Filings
    • Governance
      • Governance Documents
      • Corporate Responsibility
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • RSS Feeds
  • China
  • Japan
  • Latin America
  • Spanish
  • Portuguese
Catalent Logo
Contact Us
  • Oral
    Dose
    • Development & Bioavailability
      • Preclinical Development
      • Formulation
      • Bioavailability Enhancement
      • Integrated Development Solutions
      • OptiForm® Solution Suite
      • Catalent Xpress Pharmaceutics™
    • Dose Form Design
      • OptiDose® Design Solution
      • Tablets & Capsules
      • Orally Disintegrating Tablets
      • Softgel Technology
      • Stick Pack
    • Oral Technologies
      • Bioavailability Enhancement
      • Modified Release Formulations
      • Orally Disintegrating Tablets
      • Abuse Deterrent
      • Oral Macromolecule Delivery
    • Softgel Technologies
      • RP Scherer Softgel Technology
      • Plant Based Softgel Technology
      • Oral Macromolecule Delivery
      • Abuse Deterrent Technology
      • Smaller Easy to Swallow Softgels
    • Oral Manufacturing
      • Commercial Manufacturing
      • Scale-Up & Product Launch
      • Technology Transfers
      • OneXpress™ Solution
      • Oral Dose Packaging
    • Oral Dose Analytical Solutions
      • Solid State Screening
      • Methods Development & Validation
      • Stability Testing & Storage
    • Highly Potent Active Pharmaceutical Ingredients
  • Biologics
    • Biotherapeutics
    • Advanced Therapeutics
    • Specialty
    • Technologies
  • Specialty
    • Inhalation
      • Inhalation Development & Analytical
      • Nasal Delivery
      • Dry Powder Inhalers
    • Development & Analytical Services
    • Small Molecule Injectable
    • Regulatory Support Services
    • Orphan Drugs
    • Emerging Biotech Solutions
  • Clinical
    Supply
    • Forecasting & Planning
    • Packaging Services
    • Comparator Sourcing
    • Distribution & Logistics
  • Consumer
    • Over-The-Counter
    • Nutritional Supplements
    • Beauty
    • Product Library
  • Expert
    Content
    • Biologics
    • Clinical Supply Services
    • Consumer Health
    • Cell Therapy
    • Gene Therapy
    • Development & Bioavailability
    • Dose Form Design
    • Inhalation
    • Oral Manufacturing
    • Oral Technologies
    • Small Molecule Analytical
    • Small Molecule Injectable
    • Softgel Technologies
  • Locations
    • Asia Pacific
    • Europe
    • Latin America
    • North America
    • Site Tours
  • About Us
    • Who We Are
    • News & Events
    • Our Leadership
    • Our Scientists
    • How We Create
    • Investors
    • Corporate Responsibility
    • Diversity & Inclusion
  • Careers
Contact Us
Main menu
  • Oral Dose
    • Development & Bioavailability
      • Preclinical Development
      • Formulation
      • Bioavailability Enhancement
      • Integrated Development Solutions
      • OptiForm® Solution Suite
      • Catalent Xpress Pharmaceutics™
    • Dose Form Design
      • OptiDose® Design Solution
      • Tablets & Capsules
      • Orally Disintegrating Tablets
      • Softgel Technology
      • Stick Pack
    • Oral Technologies
      • Bioavailability Enhancement
      • Modified Release Formulations
      • Orally Disintegrating Tablets
      • Abuse Deterrent
      • Oral Macromolecule Delivery
    • Softgel Technologies
      • RP Scherer Softgel Technology
      • Plant Based Softgel Technology
      • Oral Macromolecule Delivery
      • Abuse Deterrent Technology
      • Smaller Easy to Swallow Softgels
    • Oral Manufacturing
      • Commercial Manufacturing
      • Scale-Up & Product Launch
      • Technology Transfers
      • OneXpress™ Solution
      • Oral Dose Packaging
    • Oral Dose Analytical Solutions
      • Solid State Screening
      • Methods Development & Validation
      • Stability Testing & Storage
    • Highly Potent Active Pharmaceutical Ingredients
  • Biologics
    • Biotherapeutics
    • Advanced Therapeutics
    • Specialty
    • Technologies
  • Specialty
    • Inhalation
      • Inhalation Development & Analytical
      • Nasal Delivery
      • Dry Powder Inhalers
    • Development & Analytical Services
    • Small Molecule Injectable
    • Regulatory Support Services
    • Orphan Drugs
    • Emerging Biotech Solutions
  • Clinical Supply
    • Forecasting & Planning
    • Packaging Services
    • Comparator Sourcing
    • Distribution & Logistics
  • Consumer
    • Over-The-Counter
    • Nutritional Supplements
    • Beauty
    • Product Library
  • Expert Content
    • Biologics
    • Clinical Supply Services
    • Consumer Health
    • Cell Therapy
    • Gene Therapy
    • Development & Bioavailability
    • Dose Form Design
    • Inhalation
    • Oral Manufacturing
    • Oral Technologies
    • Small Molecule Analytical
    • Small Molecule Injectable
    • Softgel Technologies
  • Locations
    • Asia Pacific
    • Europe
    • Latin America
    • North America
    • Site Tours
  • About Us
    • Who We Are
    • News & Events
    • Our Leadership
    • Our Scientists
    • How We Create
    • Investors
    • Corporate Responsibility
    • Diversity & Inclusion
  • Careers
Regional Sites
  • China
  • Japan
  • Latin America
  • Spanish
  • Portuguese

Governance Documents

Corporate Governance

Download item year list
Download Description
Corporate Governance Guidelines (opens in new window)
260 KB
Management & Board of Directors (opens in new window)
Online
Standard of Business Conduct (opens in new window)
2.72 MB
Insider Trading Policy (opens in new window)
274 KB
Fourth Amended & Restated Certificate of Incorporation (opens in new window)
3.73 MB
Bylaws (opens in new window)
278 KB

COMMITTEES

Download item year list
Download Description
Committee Composition (opens in new window)
Strategic and Operational Review Committee Charter (opens in new window)
160 KB
Nominating & Corporate Governance Committee Charter (opens in new window)
133 KB
Audit Committee Charter (opens in new window)
158 KB
Compensation and Leadership Committee Charter (opens in new window)
162 KB
Quality and Regulatory Compliance Committee Charter (opens in new window)
156 KB

Contact Us

Investor Relations Dept Catalent, Inc.
14 Schoolhouse Road
Somerset, NJ 08873
Phone: +1 732 537 6325
Fax: +1 732 537 5932
Mail: investors@catalent.com


Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Catalent, Inc. we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Catalent, Inc. to send you the requested Investor Email Alert updates.

* Required

*
Investor Alert Options
*





Unsubscribe

Email Alert Sign Up Confirmation

Expert Content Subscribe Investors Careers Contact Us Site Map
Follow Us. Share Us.
By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement
Copyright 2022, Catalent, Inc - All Rights Reserved
Terms Modern Slavery Statement